Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
Provided By PR Newswire
Last update: Mar 22, 2024
Transitioning HBV cure programs into multiple late-stage combination studies with interim results throughout 2024 and 2025 informing Company's registrational strategy
Read more at prnewswire.com
